Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash & Equivalents (2016 - 2020)

Historic Cash & Equivalents for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $20.2 million.

  • Forte Biosciences' Cash & Equivalents fell 2103.21% to $20.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $20.2 million, marking a year-over-year decrease of 2103.21%. This contributed to the annual value of $6.9 million for FY2019, which is 8299.81% down from last year.
  • Forte Biosciences' Cash & Equivalents amounted to $20.2 million in Q3 2020, which was down 2103.21% from $27.7 million recorded in Q2 2020.
  • In the past 5 years, Forte Biosciences' Cash & Equivalents ranged from a high of $76.1 million in Q2 2017 and a low of $4.1 million during Q3 2016
  • Over the past 5 years, Forte Biosciences' median Cash & Equivalents value was $20.2 million (recorded in 2020), while the average stood at $24.5 million.
  • Per our database at Business Quant, Forte Biosciences' Cash & Equivalents skyrocketed by 173077.3% in 2017 and then tumbled by 8299.81% in 2019.
  • Forte Biosciences' Cash & Equivalents (Quarter) stood at $5.5 million in 2016, then skyrocketed by 552.14% to $35.9 million in 2017, then increased by 13.58% to $40.8 million in 2018, then plummeted by 83.0% to $6.9 million in 2019, then soared by 191.11% to $20.2 million in 2020.
  • Its last three reported values are $20.2 million in Q3 2020, $27.7 million for Q2 2020, and $14.2 million during Q1 2020.